National Bank of Canada
ABCL icon

National Bank of Canada’s AbCellera Biologics ABCL Stock Holding History

National Bank of Canada’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.86K Buy
+1,393
New +$5.01K ﹤0.01% 2464
2025
Q4 		– Sell
-3,447
Closed -$17.3K – 2868
2025
Q3 		$17.3K Buy
3,447
+3,341
+3,152% +$14.7K ﹤0.01% 2187
2025
Q2 		$331 Sell
106
-3,127
-97% -$7.78K ﹤0.01% 2795
2025
Q1 		$7.14K Sell
3,233
-71,668
-96% -$206K ﹤0.01% 2310
2024
Q4 		$219K Buy
74,901
+9,804
+15% +$27.3K ﹤0.01% 1589
2024
Q3 		$169K Buy
65,097
+26,002
+67% +$72K ﹤0.01% 1418
2024
Q2 		$109K Sell
39,095
-144,790
-79% -$548K ﹤0.01% 1466
2024
Q1 		$704K Buy
183,885
+176,200
+2,293% +$899K ﹤0.01% 1195
2023
Q4 		$44K Buy
7,685
+1,600
+26% +$7.42K ﹤0.01% 1811
2023
Q3 		$27K Buy
6,085
+4,850
+393% +$29.5K ﹤0.01% 1965
2023
Q2 		$7.97K Hold
1,235
– – ﹤0.01% 2241
2023
Q1 		$9.31K Buy
1,235
+35
+3% +$318 ﹤0.01% 2159
2022
Q4 		$12.1K Sell
1,200
-1,500
-56% -$17.3K ﹤0.01% 2130
2022
Q3 		$27K Buy
2,700
+1,105
+69% +$12.1K ﹤0.01% 1917
2022
Q2 		$17K Buy
1,595
+150
+10% +$1.27K ﹤0.01% 2116
2022
Q1 		$14K Buy
1,445
+300
+26% +$2.84K ﹤0.01% 2269
2021
Q4 		$16K Buy
+1,145
New +$17.4K ﹤0.01% 2212

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

National Bank of Canada's ABCL Position: Q1 2026 in Review

National Bank of Canada opened a new position in AbCellera Biologics (ABCL) in Q1 2026: 1,393 shares worth $4.86K. The stake represents ﹤0.01% of the portfolio and ranks #2464 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in ABCL as recently as Q3 2025.

National Bank of Canada first reported a position in ABCL in Q4 2021 and has held it in 17 quarters since. The position peaked at $704K in Q1 2024. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • National Bank of Canada held 1,393 shares of AbCellera Biologics worth $4.86K as of Q1 2026.
  • AbCellera Biologics was a new National Bank of Canada position in Q1 2026.
  • AbCellera Biologics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2464 holding.
  • National Bank of Canada first reported a position in AbCellera Biologics in Q4 2021 and has held it in 17 quarters since.
  • National Bank of Canada's AbCellera Biologics position peaked at $704K in Q1 2024.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.